MKI67 and breast cancer: Due to the molecular heterogeneity, the subtypes of BC are divided according to the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), in addition to the percentage of the proliferating index (Ki67).